Alpha1H shows benefit in non-muscle invasive bladder cancer, shrinking tumors and boosting the immune system with manageable ...

Akeso enrolls first patient in pivotal phase III trial of cadonilimab for perioperative treatment of resectable gastric cancer: Hong Kong Friday, August 22, 2025, 18:00 Hrs [IST] ...

Levelle Nutrition Co-founder and CEO Linda Alvarez discusses the timely launch of Cycle Syncing Protein and its broader ...

As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of ...

AbbVie ABBV holds a dominant position in the immunology market, which is being aided by strong sales of its two new ...

UCLA’s cancer research has been deeply impactful, with millions of people receiving drugs and therapies developed in Bruin ...

Tryptamine Therapeutics has struck an exclusive deal with world-leading psychedelic researchers Professor Robin ...

USD is seeking more than $293.5 million in funding for various projects over the years to come, for everything from ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...

In response to a proposal submitted by Ravenbhel Healthcare of the fixed dose combination (FDC) pulmonary drug Bilastine 10 ...

Eli Lilly and Company LLY is a key player in the diabetes and obesity drug market, mainly due to the significant popularity ...

Chronic diseases, such as diabetes, cardiovascular conditions, autoimmune disorders, and cancer, represent an escalating global health challenge, exerting ...